This company has been marked as potentially delisted and may not be actively trading. Agile Therapeutics (AGRX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Agile Therapeutics Short Interest DataAgile Therapeutics (AGRX) has a short interest of 361,300 shares, representing 12.68% of the float (the number of shares available for trading by the public). This marks a 62.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 352,864 shares to cover all short positions.Current Short Interest361,300 sharesPrevious Short Interest222,100 sharesChange Vs. Previous Month+62.67%Dollar Volume Sold Short$196,185.90Short Interest Ratio0.5 Days to CoverLast Record DateMarch 15, 2024Outstanding Shares6,856,000 sharesFloat Size2,850,000 sharesShort Percent of Float12.68%Today's Trading Volume120,938 sharesAverage Trading Volume352,864 sharesToday's Volume Vs. Average34% Short Selling Agile Therapeutics? Sign up to receive the latest short interest report for Agile Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAGRX Short Interest Over TimeAGRX Days to Cover Over TimeAGRX Percentage of Float Shorted Over Time Agile Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2024361,300 shares $196,185.90 +62.7%12.7%0.5 $0.54 2/29/2024222,100 shares $176,569.50 +4.2%7.9%0.6 $0.80 2/15/2024213,100 shares $260,493.44 +12.2%7.5%0.6 $1.22 1/31/2024189,900 shares $290,547.00 +129.9%6.7%2.8 $1.53 1/15/202482,600 shares $154,462.00 +287.8%3.4%1.3 $1.87 12/31/202321,300 shares $41,535.00 +156.6%0.9%0.4 $1.95 12/15/20238,300 shares $16,766.00 +23.9%0.4%0.2 $2.02 11/30/20236,700 shares $13,869.00 -62.8%0.3%0.2 $2.07 11/15/202318,000 shares $40,140.00 +12.5%0.8%0.4 $2.23 10/31/202316,000 shares $28,960.00 +263.6%0.9%0.4 $1.81 Get the Latest News and Ratings for AGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Agile Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/20234,400 shares $7,832.00 -76.5%0.2%0.1 $1.78 9/30/202318,700 shares $44,880.00 +567.9%1.0%0.4 $2.40 9/15/20232,800 shares $5,852.00 -73.8%0.2%0.1 $2.09 8/31/202310,700 shares $27,820.00 -48.3%0.6%0.1 $2.60 8/15/202320,700 shares $45,126.00 -46.2%1.1%0.2 $2.18 7/31/202338,500 shares $111,650.00 -45.8%1.4%0.3 $2.90 7/15/202371,000 shares $202,350.00 -42.5%2.5%0.6 $2.85 6/30/2023123,400 shares $364,030.00 -36.7%4.4%1.1 $2.95 6/15/2023194,800 shares $633,100.00 +146.3%6.7%1.9 $3.25 5/31/202379,100 shares $299,789.00 +16.5%2.7%2.8 $3.79 5/15/202367,900 shares $322,525.00 +46.0%6.9%2.6 $4.75 4/30/202346,500 shares $299,925.00 +37.6%5.3%2.4 $6.45 4/15/202333,800 shares $235,924.00 +350.7%3.8%1.8 $6.98 3/31/20237,500 shares $1,680.00 -96.7%0.9%0.4 $0.22 3/15/2023225,700 shares $48,818.91 -39.7%0.6%0.3 $0.22 2/28/2023374,400 shares $89,818.56 -28.7%1.0%0.5 $0.24 2/15/2023524,900 shares $152,221.00 -25.0%1.3%0.7 $0.29 1/31/2023699,500 shares $188,865.00 +2.5%1.8%0.8 $0.27 1/15/2023682,600 shares $197,954.00 -0.1%1.7%0.8 $0.29 12/30/2022683,200 shares $155,086.40 -0.1%1.7%0.8 $0.23 12/15/2022684,100 shares $132,715.40 -18.7%1.7%0.8 $0.19 11/30/2022841,200 shares $176,652.00 -22.8%2.1%0.8 $0.21 11/15/20221,090,000 shares $253,207.00 -31.0%2.8%0.9 $0.23 10/31/20221,580,000 shares $440,820.00 +29.5%4.2%0.8 $0.28 10/15/20221,220,000 shares $318,786.00 -2.4%3.2%0.5 $0.26 9/30/20221,250,000 shares $371,125.00 -15.0%3.3%0.3 $0.30 9/15/20221,470,000 shares $588,000.00 -6.4%3.9%0.1 $0.40 8/31/20221,570,000 shares $631,925.00 -19.5%4.1%0.1 $0.40 8/15/20221,950,000 shares $1.05 million +42.3%5.1%0.2 $0.54 7/31/20221,370,000 shares $699,933.00 +77.4%3.6%0.1 $0.51Trump to redistribute trillions of dollars (Ad)What’s most shocking about this list for me is stock #2. It’s primed to be the biggest beneficiary of the DOGE administration’s efforts to eradicate the filth and corruption plaguing our government. But the thing is… it’s actually not an Elon stock.After that… it might be too little, too late. View the list here NOW. 7/15/2022772,200 shares $427,026.60 -73.7%2.0%0.1 $0.55 6/30/20222,940,000 shares $3.43 million +510.5%7.8%0.3 $1.17 6/15/2022481,600 shares $587,552.00 -4.2%10.9%1 $1.22 5/31/2022502,600 shares $703,640.00 +126.7%11.4%1.2 $1.40 5/15/2022221,700 shares $361,371.00 -22.7%5.0%0.6 $1.63 4/30/2022286,900 shares $657,001.00 -88.5%N/A0.9 $2.29 4/15/20222,500,000 shares $407,500.00 +95.3%N/A0.3 $0.16 3/31/20221,280,000 shares $268,160.00 -33.0%N/A0.7 $0.21 3/15/20221,910,000 shares $458,591.00 +34.5%N/A1.7 $0.24 2/28/20221,420,000 shares $434,520.00 +2.2%N/A1.2 $0.31 2/15/20221,390,000 shares $463,565.00 -14.2%N/A1 $0.33 1/31/20221,620,000 shares $565,380.00 -28.6%N/A1.1 $0.35 1/15/20222,270,000 shares $862,600.00 -7.7%N/A1.5 $0.38 12/31/20212,460,000 shares $1.20 million +2.1%N/A1.2 $0.49 12/15/20212,410,000 shares $1.41 million +54.5%N/A1.1 $0.58 11/30/20211,560,000 shares $982,800.00 +8.3%N/A0.8 $0.63 11/15/20211,440,000 shares $1.07 million -11.7%N/A0.8 $0.75 10/29/20211,630,000 shares $1.29 million +14.0%N/A1 $0.79 10/15/20211,430,000 shares $1.09 million -42.6%N/A0.9 $0.76 9/30/20212,490,000 shares $2.39 million +1.2%3.0%2.5 $0.96 9/15/20212,460,000 shares $2.61 million -7.5%2.9%2.9 $1.06 8/31/20212,660,000 shares $3.09 million +13.2%3.2%3 $1.16 8/13/20212,350,000 shares $2.42 million -4.9%2.8%2.6 $1.03 7/30/20212,470,000 shares $2.96 million +1.7%3.0%2.6 $1.20 7/15/20212,430,000 shares $2.99 million -12.6%3.1%2.4 $1.23 6/30/20212,780,000 shares $3.70 million -57.1%3.5%2.6 $1.33 6/15/20216,480,000 shares $9.85 million +3.4%8.2%6.4 $1.52 5/28/20216,270,000 shares $10.09 million +3.5%7.9%5.1 $1.61 5/14/20216,060,000 shares $8.67 million +8.0%N/A4.2 $1.43 4/30/20215,610,000 shares $10.21 million +17.1%N/A3.5 $1.82 4/15/20214,790,000 shares $9.10 million +11.4%N/A3 $1.90 3/31/20214,300,000 shares $8.56 million +10.0%N/A2.7 $1.99 3/15/20213,910,000 shares $8.60 million +45.9%N/A2.5 $2.20 2/26/20212,680,000 shares $8.15 million +14.0%N/A2 $3.04 2/12/20212,350,000 shares $7.87 million -1.3%N/A1.9 $3.35 1/29/20212,380,000 shares $6.74 million -18.5%N/A2.1 $2.83 1/15/20212,920,000 shares $8.29 million -2.3%N/A3 $2.84 12/31/20202,990,000 shares $8.70 million -11.8%N/A3.4 $2.91 12/15/20203,390,000 shares $10.03 million -3.1%N/A3.8 $2.96 11/30/20203,500,000 shares $9.59 million +1.2%N/A3.2 $2.74 11/15/20203,460,000 shares $9.93 million -1.7%N/A3.2 $2.87 10/30/20203,520,000 shares $10.42 million +5.4%N/A3 $2.96 10/15/20203,340,000 shares $10.12 million +3.1%N/A2.7 $3.03 9/30/20203,240,000 shares $9.85 million -23.9%N/A2.5 $3.04 9/15/20204,260,000 shares $15.80 million -8.4%N/A2.7 $3.71 8/31/20204,650,000 shares $14.88 million -6.3%N/A2.9 $3.20 8/14/20204,960,000 shares $14.09 million +13.5%N/A2.9 $2.84 7/31/20204,370,000 shares $10.93 million -3.1%N/A2.6 $2.50 7/15/20204,510,000 shares $11.46 million -3.8%N/A2.1 $2.54 6/30/20204,690,000 shares $13.04 million +60.1%N/A2.1 $2.78Trump to redistribute trillions of dollars (Ad)What’s most shocking about this list for me is stock #2. It’s primed to be the biggest beneficiary of the DOGE administration’s efforts to eradicate the filth and corruption plaguing our government. But the thing is… it’s actually not an Elon stock.After that… it might be too little, too late. View the list here NOW. 6/15/20202,930,000 shares $8.41 million +2.1%N/A1.4 $2.87 5/29/20202,870,000 shares $8.09 million -5.6%N/A1.3 $2.82 5/15/20203,040,000 shares $7.87 million +48.3%N/A1.1 $2.59 AGRX Short Interest - Frequently Asked Questions What is Agile Therapeutics' current short interest? Short interest is the volume of Agile Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 361,300 shares of AGRX short. 12.68% of Agile Therapeutics' shares are currently sold short. Learn More on Agile Therapeutics' current short interest. What is a good short interest percentage for Agile Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.68% of Agile Therapeutics' floating shares are currently sold short. Is Agile Therapeutics' short interest increasing or decreasing? Agile Therapeutics saw a increase in short interest in March. As of March 15th, there was short interest totaling 361,300 shares, an increase of 62.7% from the previous total of 222,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Agile Therapeutics' float size? Agile Therapeutics currently has issued a total of 6,856,000 shares. Some of Agile Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Agile Therapeutics currently has a public float of 2,850,000 shares. How does Agile Therapeutics' short interest compare to its competitors? 12.68% of Agile Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Agile Therapeutics: Verrica Pharmaceuticals Inc. (10.85%), Estrella Immunopharma, Inc. (0.02%), Reviva Pharmaceuticals Holdings, Inc. (15.65%), Lantern Pharma Inc. (3.40%), bluebird bio, Inc. (5.24%), Barinthus Biotherapeutics plc (0.05%), Alterity Therapeutics Limited (0.39%), Xilio Therapeutics, Inc. (3.55%), Scilex Holding (4.63%), SCYNEXIS, Inc. (1.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Agile Therapeutics stock? Short selling AGRX is an investing strategy that aims to generate trading profit from Agile Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Agile Therapeutics? A short squeeze for Agile Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AGRX, which in turn drives the price of the stock up even further. How often is Agile Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGRX, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies Verrica Pharmaceuticals Short Interest Data Estrella Immunopharma Short Interest Data Reviva Pharmaceuticals Short Interest Data Lantern Pharma Short Interest Data bluebird bio Short Interest Data Barinthus Biotherapeutics Short Interest Data Alterity Therapeutics Short Interest Data Xilio Therapeutics Short Interest Data Scilex Short Interest Data SCYNEXIS Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AGRX) was last updated on 5/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredThis robot is coming to 65 million Americans … this year.The Robotics Revolution has arrived. And not surprisingly, Nvidia is leading the way. Nvidia CEO Jensen ...Weiss Ratings | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew breed of trader (Wall Street hates us?)Wall Street big wigs and old-money bankers can’t touch this 1 type of stock. And that opens the door for tr...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agile Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agile Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AGRX Stock Free AGRX Stock Alerts